← SynDRA
AR-C155858
SynDRA canonical compound SYN0388446 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SLC16A1 | SLC16A7 |
|---|
| Mechanism of action | monocarboxylate transporter inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:538915
- DTXCID90387817
- MFCD22124476
- AR-C 155858
- ISIVOJWVBJIOFM-ZDUSSCGKSA-N
- A1EH2
- orb1308642
- SCHEMBL3826451
- BDBM21998
- C21H27N5O5S
- CHEBI:234387
- Thienopyrimidine-2,4-dione, 13
- GLXC-07354
- EX-A3215
- WUA79137
- EBC-46248
- s7919
- AKOS024458436
- CS-0540
- SR13801
- AR-C155858?
- NCGC00250392-01
- NCGC00250392-02
- NCGC00250392-03
- AC-35187
- AS-75244
- HY-13248
- SY027484
- DB-236643
- AR-​C155858
- EN300-7410898
- F980501
- AR-C155858,CAS;496791-37-8
- BRD-K42325600-001-01-8
- (S)-6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-5-[(4-hydroxyisoxazolidin-2-yl)carbonyl]-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
Look up AR-C155858 in the interactive SynDRA portal →